Journal article

The NS Segment of an H5N1 Highly Pathogenic Avian Influenza Virus (HPAIV) Is Sufficient To Alter Replication Efficiency, Cell Tropism, and Host Range of an H7N1 HPAIV

Wenjun Ma, Dominique Brenner, Zhongfang Wang, Bianca Dauber, Christina Ehrhardt, Katrin Hoegner, Susanne Herold, Stephan Ludwig, Thorsten Wolff, Kangzhen Yu, Juergen A Richt, Oliver Planz, Stephan Pleschka

Journal of Virology | AMER SOC MICROBIOLOGY | Published : 2010

University of Melbourne Researchers

Grants

Awarded by DFG


Awarded by EU


Awarded by FluResearchNet-Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses


Awarded by DFG Graduate School


Awarded by University of Munster


Awarded by NIH


Awarded by Priority 1 Life Sciences, Genomics and Biotechnology for Health


Funding Acknowledgements

This work was supported in part by grants of the DAAD (fellowship to W. M.) and the DFG (GRK1384 fellowship to Z. W.) and in part by grants of the European Specific Targeted Research Project, EuroFlu Molecular Factors and Mechanisms of Transmission and Pathogenicity of Highly Pathogenic Avian Influenza Virus, funded by the 6th Framework Program (FP6) of the EU (SP5B-CT-2007-044098, to S. P., S. L., and O. P.); the FluResearchNet-Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses (01 KI 07136 to S. P.); the DFG Graduate School (GRK1409) and the interdisciplinary Clinical Research Centre (IZKF) of the University of Munster (Lud27032/06 to S. L.); the Influenza Research Program FSI of the Federal German Government (to T. W. and O. P.); and NIH funding (contract HHSN266200700005C to J. A. R.). Furthermore, this work is a part of the activities of the VIRGIL European Network of Excellence on Antiviral Drug Resistance supported by a grant (LSH-MCT-2004-503359) from the Priority 1 Life Sciences, Genomics and Biotechnology for Health program (FP6) (to S. P. S. L., and O. P.).